SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing heavy volume and a surge in bullish sentiment following an earnings report that highlighted improved profit margins and a strong pipeline for its AI infrastructure, leading many in the community to anticipate a significant price re-rating. While retail investors are aggressively debating the potential for a short squeeze and long-term valuation recovery, others remain cautious due to ongoing regulatory scrutiny and historical volatility.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is capturing market attention as the community rallies behind its pivot from smartphones to a software-driven cybersecurity and physical AI company, bolstered by a significant Wall Street Journal spotlight and a high-profile presence at upcoming robotics expos. Investors are actively discussing the stock's potential for a major revaluation, citing robust institutional volume, a massive backlog in automotive and robotics technology, and the potential for a sustained breakout above its recent trading range.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant community buzz as investors anticipate potential global partnership announcements and updates regarding its AI-driven immunotherapy manufacturing technology. The discussion is heavily centered on a potential short squeeze, with retail traders pointing to high short interest and limited float as key drivers for a potential sharp upward move.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending as investors debate whether the company's recent earnings beat and strategic partnership with Disney signal a long-term turnaround or further decline. Community discussion is heavily divided, with some betting on a potential short squeeze fueled by high short interest and institutional interest, while others express frustration over past stock performance and skepticism regarding management's profitability targets.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors gear up for the imminent close of its Northern Data acquisition, a move widely viewed as a catalyst that could unlock significant AI and cloud computing potential. The community is heavily focused on the stock's record-high short interest and strong backing from Tether, leading to intense debates over the potential for a major short squeeze.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as market sentiment turns bullish, driven by expectations of a blockbuster year for Briumvi, strong commercial execution, and anticipation of upcoming trial readouts for subcutaneous formulations and Azer-cel. The community is actively discussing the potential for a strategic buyout and observing significant institutional accumulation, which many believe is positioning the stock for a breakout beyond current resistance levels.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is currently trending after an official determination from NOAA declared its deep-seabed mining application fully compliant, a key regulatory milestone that clarifies the path toward commercial recovery permits. The investment community is actively debating the significance of this development for long-term production timelines and the company's role in the critical minerals supply chain, while some investors monitor potential volatility associated with institutional selling and expiring options.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors digest a positive earnings report showing significant revenue beats and reduced operating costs while keeping a close eye on the expanding Matrix-M platform, which is currently being explored for over 30 infectious disease and oncology applications. The community is actively debating the potential for future partnerships with global pharma giants and closely tracking activist investor pressure to optimize capital allocation and management structure.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing significant volatility and intense community debate as investors navigate a disconnect between its strong product demand and a persistent slide toward 52-week lows ahead of upcoming earnings. Market participants are actively discussing institutional manipulation, potential channel stuffing concerns, and the competitive impact of private-label energy drinks, while bulls continue to position for a post-earnings recovery fueled by the company's growth narrative.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is trending after announcing a strategic manufacturing partnership with Cellipont Bioservices to advance its ERNA-101 ovarian cancer cell therapy toward clinical trials. Community sentiment is highly polarized, with retail traders focusing on the stock's low float and short-squeeze potential, while critics remain skeptical, highlighting the company's history of reverse splits and dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
